Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

Racial Disparities in Survival Outcomes Shown in Pediatric Hodgkin Lymphoma Patients

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

$1.5M Awarded from ORIEN New Oncologic Visionary Awards Program Supports Research by Rutgers Cancer Institute Investigators

A pair of Rutgers Cancer Institute of New Jersey physician-scientists are collaborating on national research projects that received $1.5 million in combined funding from the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program.

RWJBarnabas Health and Rutgers Cancer Institute Announce New $750 Million, Free-Standing Cancer Pavilion in New Brunswick

NEW BRUNSWICK, N.J., June 19, 2019 – RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, in partnership with New Brunswick Development Corporation have announced the development of a new, state-of-the-art, free-standing cancer pavilion in New Brunswick. The initial estimated…